Company profile
Resonate Blends, Inc.
OTC: KOAN · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ North Bergen, CACIK 0000897078Reports USD
#807 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 33GM —SS 40
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), 3-yr revenue growth · ↓ workforce scale, growth stability
Methodology →Revenue TTM
$1.5M
Rev growth YoY (TTM)
-32.1%
Net income (FY)
-$2.1M
Employees
2
as of 2026-08-28
Market cap
$78.1k
as of 2026-08-28
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.9M$1.9M2024
Net income-$2.1M-$2.1M2024
Operating income-$1.7M-$1.7M2024
Total assets$1.9M$1.9M2024
Liabilities$3.1M$3.1M2023
Equity-$3.2M-$3.2M2024
Revenue trend
FY2016 – FY2024 · USD
FY16
FY18
FY18
FY19
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Resonate Blends, Inc.’s revenue?
Resonate Blends, Inc. booked $1.9M in FY2024 revenue, growing 11415% year over year — faster than 99% of Healthcare companies we track, at a -112.5% net margin.
Peers · Healthcare
Longevity Health Holdings Inc.22DVeltex Corporation50DBio Essence Corporation52DVycor Medical, Inc.56CPharmaCielo Ltd.40DWest Island Brands Inc.——Key facts
CEOJames W. Zimbler
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersNorth Bergen, CA
ExchangeOTC: KOAN
Employees2
IPO date1993-03-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.